How much is Astarte Medical worth in 2026?

Astarte Medical has a current valuation of N/A based on their Later Stage VC (Series A1) round and secondary market data.

How much funding has Astarte Medical raised?

Astarte Medical has raised N/A in total funding across 2 funding rounds.

Astarte Medical

Decision/Risk Analysis

Astarte Medical valuation and funding history | Last updated: September 22, 2021 | 2 funding rounds

Current Valuation

N/A

As of September 22, 2021

Total Funding Raised

N/A

Across 2 rounds

Last Round

Later Stage VC (Series A1)

$7.6M

Last Funding

Sep 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 22, 2021	Later Stage VC (Series A1)	$7.6M	N/A	-
April 30, 2019	Early Stage VC (Series A)	$5.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Astarte Medical is currently valued at N/A as of September 22, 2021.

Track Astarte Medical Valuation Updates

Get notified when Astarte Medical raises new funding or valuation changes

Explore More Data

Detailed analysis for Astarte Medical

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Astarte Medical's valuation history, funding rounds, and growth metrics.

No credit card required

What is Astarte Medical Worth in 2026?

Astarte Medical is a leading private company in the Decision/Risk Analysis sector. Track Astarte Medical's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Astarte Medical Valuation is Determined

Private company valuations like Astarte Medical's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.